Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Hanmi formulations deal set to extend GSK's emerging markets reach

This article was originally published in Scrip

Executive Summary

GlaxoSmithKline is continuing its push into emerging markets through a new alliance with the South Korean firm Hanmi Pharm that will focus on the co-development and global commercialisation of "evidence-based formulations".

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register